Revolution Medicines, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
ICLRICON plc -2.38%240.432.8%$124.12m
ARGXargenx SE 2.38%381.830.0%$89.82m
VRXValeant Pharmaceuticals International, Inc. -5.43%6.0214.1%$35.42m
RVMDRevolution Medicines, Inc. -7.04%24.170.0%$29.44m
USNAUSANA Health Sciences, Inc. -0.64%71.974.2%$4.62m
ENVBEnveric Biosciences, Inc. -0.29%6.910.0%$4.60m
ANIKAnika Therapeutics, Inc. -1.43%22.809.7%$1.76m
CLVRClever Leaves Holdings, Inc. -6.20%0.980.0%$1.69m
BGXXBright Green Corp. -3.23%1.200.0%$0.98m
CDTXCidara Therapeutics, Inc. 5.85%0.710.7%$0.62m
CDXCChromadex Corp. -0.90%1.662.7%$0.59m
FLGCFlora Growth Corp. 5.45%0.930.0%$0.55m
PMCBPharmaCyte Biotech, Inc. 3.27%2.840.0%$0.51m
IBIOiBio, Inc. 4.69%0.290.2%$0.49m
SMFLSmart for Life, Inc. -6.61%0.570.0%$0.42m

Company Profile

Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.